Renaissance Technologies LLC raised its position in Arteris, Inc. (NASDAQ:AIP - Free Report) by 29.5% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 183,865 shares of the company's stock after buying an additional 41,865 shares during the period. Renaissance Technologies LLC owned about 0.46% of Arteris worth $1,874,000 at the end of the most recent quarter.
A number of other large investors have also modified their holdings of AIP. State Street Corp lifted its holdings in Arteris by 18.5% during the third quarter. State Street Corp now owns 410,578 shares of the company's stock valued at $3,170,000 after purchasing an additional 64,081 shares in the last quarter. Barclays PLC increased its stake in Arteris by 321.1% during the 3rd quarter. Barclays PLC now owns 39,396 shares of the company's stock worth $304,000 after buying an additional 30,041 shares in the last quarter. Geode Capital Management LLC raised its holdings in shares of Arteris by 6.6% during the third quarter. Geode Capital Management LLC now owns 597,116 shares of the company's stock valued at $4,610,000 after acquiring an additional 36,908 shares during the last quarter. Franklin Resources Inc. lifted its position in shares of Arteris by 0.8% in the third quarter. Franklin Resources Inc. now owns 1,491,415 shares of the company's stock valued at $11,201,000 after acquiring an additional 12,375 shares in the last quarter. Finally, JPMorgan Chase & Co. boosted its stake in shares of Arteris by 67.1% in the third quarter. JPMorgan Chase & Co. now owns 92,242 shares of the company's stock worth $712,000 after acquiring an additional 37,032 shares during the last quarter. Institutional investors and hedge funds own 64.36% of the company's stock.
Insider Buying and Selling at Arteris
In related news, CFO Nicholas B. Hawkins sold 11,000 shares of the firm's stock in a transaction on Monday, February 3rd. The stock was sold at an average price of $10.33, for a total transaction of $113,630.00. Following the sale, the chief financial officer now owns 154,308 shares of the company's stock, valued at approximately $1,594,001.64. This trade represents a 6.65 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO K Charles Janac sold 50,000 shares of the stock in a transaction dated Monday, February 3rd. The stock was sold at an average price of $10.33, for a total value of $516,500.00. Following the transaction, the chief executive officer now owns 9,907,691 shares of the company's stock, valued at approximately $102,346,448.03. The trade was a 0.50 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 100,927 shares of company stock worth $918,829. 33.70% of the stock is owned by company insiders.
Arteris Stock Performance
Arteris stock traded up $0.16 during midday trading on Thursday, hitting $6.82. 19,138 shares of the company's stock were exchanged, compared to its average volume of 201,902. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.17 and a current ratio of 1.17. Arteris, Inc. has a 12-month low of $5.46 and a 12-month high of $12.64. The firm's 50 day simple moving average is $7.17 and its 200 day simple moving average is $8.61. The stock has a market cap of $282.74 million, a price-to-earnings ratio of -7.84 and a beta of 1.31.
Arteris (NASDAQ:AIP - Get Free Report) last issued its earnings results on Tuesday, February 18th. The company reported ($0.19) earnings per share for the quarter, missing the consensus estimate of ($0.11) by ($0.08). The company had revenue of $15.49 million for the quarter, compared to analyst estimates of $15.34 million. Arteris had a negative return on equity of 828.71% and a negative net margin of 58.27%. Equities research analysts predict that Arteris, Inc. will post -0.73 EPS for the current year.
Wall Street Analyst Weigh In
AIP has been the subject of several research reports. Rosenblatt Securities reaffirmed a "buy" rating and set a $15.00 price objective on shares of Arteris in a research note on Tuesday, February 18th. Northland Securities increased their price target on Arteris from $14.00 to $16.00 and gave the company an "outperform" rating in a report on Wednesday, February 19th.
Get Our Latest Research Report on Arteris
About Arteris
(
Free Report)
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
Featured Articles

Before you consider Arteris, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.
While Arteris currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.